Results
|
261.
|
|
|
262.
|
NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay. [electronic resource] by
- Giusti, Delphine
- Bini, Estela
- Terryn, Christine
- Didier, Kevin
- Le Jan, Sébastien
- Gatouillat, Grégory
- Durlach, Anne
- Nesmond, Stéphane
- Muller, Celine
- Bernard, Philippe
- Antonicelli, Frank
- Pham, Bach Nga
Producer: 20200914
In:
Frontiers in immunology vol. 10
Availability: No items available.
|
|
263.
|
Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial. [electronic resource] by
- Dohm, Ammoren
- Su, Jing
- McTyre, Emory R
- Taylor, James M
- Miller, Lance D
- Petty, W Jeffrey
- Xing, Fei
- Lo, Hui-Wen
- Metheny-Barlow, Linda J
- O'Neill, Stacey
- Bellinger, Christina
- Dotson, Travis
- Pasche, Boris
- Watabe, Kounosuke
- Chan, Michael D
- Ruiz, Jimmy
Producer: 20190911
In:
The International journal of biological markers vol. 34
Availability: No items available.
|
|
264.
|
|
|
265.
|
|
|
266.
|
|
|
267.
|
|
|
268.
|
|
|
269.
|
|
|
270.
|
|
|
271.
|
Transforming growth factor-beta induces development of the T(H)17 lineage. [electronic resource] by
- Mangan, Paul R
- Harrington, Laurie E
- O'Quinn, Darrell B
- Helms, Whitney S
- Bullard, Daniel C
- Elson, Charles O
- Hatton, Robin D
- Wahl, Sharon M
- Schoeb, Trenton R
- Weaver, Casey T
Producer: 20060608
In:
Nature vol. 441
Availability: No items available.
|
|
272.
|
|
|
273.
|
|
|
274.
|
Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. [electronic resource] by
- Benham, Helen
- Rehaume, Linda M
- Hasnain, Sumaira Z
- Velasco, Jared
- Baillet, Athan C
- Ruutu, Merja
- Kikly, Kristine
- Wang, Ran
- Tseng, Hsu-Wen
- Thomas, Gethin P
- Brown, Matthew A
- Strutton, Geoffrey
- McGuckin, Michael A
- Thomas, Ranjeny
Producer: 20140909
In:
Arthritis & rheumatology (Hoboken, N.J.) vol. 66
Availability: No items available.
|
|
275.
|
|
|
276.
|
Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial. [electronic resource] by
- Papp, K
- Thaçi, D
- Reich, K
- Riedl, E
- Langley, R G
- Krueger, J G
- Gottlieb, A B
- Nakagawa, H
- Bowman, E P
- Mehta, A
- Li, Q
- Zhou, Y
- Shames, R
Producer: 20160913
In:
The British journal of dermatology vol. 173
Availability: No items available.
|
|
277.
|
|
|
278.
|
Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. [electronic resource] by
- Happel, Kyle I
- Dubin, Patricia J
- Zheng, Mingquan
- Ghilardi, Nico
- Lockhart, Christie
- Quinton, Lee J
- Odden, Anthony R
- Shellito, Judd E
- Bagby, Gregory J
- Nelson, Steve
- Kolls, Jay K
Producer: 20051115
In:
The Journal of experimental medicine vol. 202
Availability: No items available.
|
|
279.
|
|
|
280.
|
|